Effect of Oral Hygiene with 0.12% Chlorhexidine Gluconate on the Incidence of Nosocomial Pneumonia in Children Undergoing Cardiac Surgery
Objective. To evaluate the effect of oral hygiene with 0.12% chlorhexidine gluconate on the incidence of nosocomial pneumonia and ventilator-associated pneumonia (VAP) in children undergoing cardiac surgery. Design. Prospective, randomized, double-blind, placebo-controlled trial. Setting. Pediatric...
Saved in:
Published in: | Infection control and hospital epidemiology Vol. 32; no. 6; pp. 591 - 596 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chicago, IL
University of Chicago Press
01-06-2011
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective. To evaluate the effect of oral hygiene with 0.12% chlorhexidine gluconate on the incidence of nosocomial pneumonia and ventilator-associated pneumonia (VAP) in children undergoing cardiac surgery.
Design. Prospective, randomized, double-blind, placebo-controlled trial.
Setting. Pediatric intensive care unit (PICU) at a tertiary care hospital.
Patients. One hundred sixty children undergoing surgery for congenital heart disease, randomized into 2 groups: chlorhexidine (
) and control (
).
Interventions. Oral hygiene with 0.12% chlorhexidine gluconate or placebo preoperatively and twice a day postoperatively until PICU discharge or death.
Results. Patients in experimental and control groups had similar ages (median, 12.2 vs 10.8 months;
) and risk adjustment for congenital heart surgery 1 score distribution (66% in category 1 or 2 in both groups;
). The incidence of nosocomial pneumonia was 29.8% versus 24.6% (
) and the incidence of VAP was 18.3% versus 15% (
) in the chlorhexidine and the control group, respectively. There was no difference in intubation time (
), need for reintubation (
), time interval between hospitalization and nosocomial pneumonia diagnosis (
), time interval between surgery and nosocomial pneumonia diagnosis (
), and time on antibiotics (
) and vasoactive drugs (
) between groups. Median length of PICU stay (3 vs 4 days;
), median length of hospital stay (12 vs 11 days;
), and 28-day mortality (5.7% vs 6.8%;
) were also similar in the chlorhexidine and the control group.
Conclusions. Oral hygiene with 0.12% chlorhexidine gluconate did not reduce the incidence of nosocomial pneumonia and VAP in children undergoing cardiac surgery.
Trial registration. ClinicalTrials.gov identifier: NCT00829842. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 ObjectType-Feature-1 |
ISSN: | 0899-823X 1559-6834 |
DOI: | 10.1086/660018 |